- Home
- AIRT vs GNTA Comparison
AIRT vs GNTA Comparison
Compare AIRT & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | GNTA |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.8M | 62.7M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIRT | GNTA |
|---|---|---|
| Price | $29.37 | $1.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.7K | ★ 41.6K |
| Earning Date | 02-13-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1393.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $286,834,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.98 | N/A |
| 52 Week Low | $18.35 | $0.55 |
| 52 Week High | $35.00 | $10.00 |
Technical Indicators
Market Signals| Indicator | AIRT | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 37.92 |
| Support Level | $20.19 | $0.58 |
| Resistance Level | $30.36 | $1.70 |
| Average True Range (ATR) | 2.05 | 0.08 |
| MACD | -0.40 | -0.01 |
| Stochastic Oscillator | 31.55 | 19.57 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include overnight air cargo, ground support equipment, commercial aircraft, engines and parts, digital solutions, and regional airline. The company generates maximum revenue from the overnight air cargo segment.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.